Non-Canonical Peptide Self-Assembly for Mitochondria-Specific Cargo Delivery
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
This proof-of-concept study establishes noncanonical peptide self-assembly as a ligand-free supramolecular strategy for mitochondrial drug delivery and immune modulation in tumor therapy.
Limitation the authors admit
This proof-of-concept study establishes noncanonical peptide self-assembly as a ligand-free supramolecular strategy for mitochondrial drug delivery and immune modulation in tumor therapy.
Appeared: Thursday, September 24. Journal of the American Chemical Society. Peer-reviewed journal.
DOI: 10.1021/jacs.6c16062